Overview

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
disulfiram is a DNA methyltransferase inhibitor that may provide benefit for patients with prostate cancer by restoring tumor suppressor genes.
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Treatments:
Disulfiram